RegMed Competitive and Market Intelligence, 1/11/12, market struggles to turn higher as EU declines on debt concerns but, waiting for headwinds
The 6 W’s: Who, what, where, when, why and what of it … Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Tracy Lefteroff, National Life Sciences partner, PwC US speaks … Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…
End of Day, Cause and Effect … Read more…
KOOL has entered into 5 year collaboration with Arthrex Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Stem cell-enriched autologous fat enables … sustainable … breast augmentation Read more…
OTCBB: IMUC priced an offering of 9,489,436 units, Read more…
Amorcyte’s, a NeoStem company (NYSE Amex: NBS) patent award Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.